Metformin versus Insulin for the Treatment of Gestational Diabetes
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Metformin is a logical treatment for women with gestational diabetes mellitus, but randomized trials to assess the efficacy and safety of its use for this condition are lacking. METHODS: We randomly assigned 751 women with gestational diabetes mellitus at 20 to 33 weeks of gestation to open treatment with metformin (with supplemental insulin if required) or insulin. The primary outcome was a composite of neonatal hypoglycemia, respiratory distress, need for phototherapy, birth trauma, 5-minute Apgar score less than 7, or prematurity. The trial was designed to rule out a 33% increase (from 30% to 40%) in this composite outcome in infants of women treated with metformin as compared with those treated with insulin. Secondary outcomes included neonatal anthropometric measurements, maternal glycemic control, maternal hypertensive complications, postpartum glucose tolerance, and acceptability of treatment. RESULTS: Of the 363 women assigned to metformin, 92.6% continued to receive metformin until delivery and 46.3% received supplemental insulin. The rate of the primary composite outcome was 32.0% in the group assigned to metformin and 32.2% in the insulin group (relative risk, 0.99 [corrected]; 95% confidence interval, 0.80 [corrected] to 1.23 [corrected]). More women in the metformin group than in the insulin group stated that they would choose to receive their assigned treatment again (76.6% vs. 27.2%, P<0.001). The rates of other secondary outcomes did not differ significantly between the groups. There were no serious adverse events associated with the use of metformin. CONCLUSIONS: In women with gestational diabetes mellitus, metformin (alone or with supplemental insulin) is not associated with increased perinatal complications as compared with insulin. The women preferred metformin to insulin treatment. (Australian New Zealand Clinical Trials Registry number, 12605000311651.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While individual RCTs support limited efficacy of metformin (73,74) and glyburide (75) in reducing glucose levels for the treatment of GDM, these agents are not recommended as the first-line treatment for GDM because they are known to cross the placenta and data on long-term safety for offspring is of some concern (35).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [73]
In the citing paper
“It was concluded that metformin alone, or with supplemental insulin, was not associated with increased perinatal complications.”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [112]
In the citing paper
“Blood glucose-lowering pharmacological therapy is effective at improving outcomes in women with gestational diabetes whose hyperglycemia does not respond sufficiently to lifestyle therapy (71, 82, 88–90).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [90]
In the citing paper
“Blood glucose-lowering pharmacological therapy is effective at improving outcomes in women with gestational diabetes whose hyperglycemia does not respond sufficiently to lifestyle therapy (71, 82, 88–90).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [89]
In the citing paper
“Glyburide is effective in controlling blood glucose in women with gestational diabetes”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [90]
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Dabelea, D., Hanson, R. L., Lindsay, R. S., Pettitt, D. J., Imperatore, G., Gabir, M. M., Roumain, J., Bennett, P. H., & Knowler, W. C. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2208 · Cited by 1,277
Kirpichnikov, D., McFarlane, S. I., & Sowers, J. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00009 · Cited by 1,084
A comparison of glyburide and insulin in women with gestational diabetes mellitus
Langer, O., Conway, D. L., Berkus, M. D., Xenakis, E. M.-J., & Gonzales, O. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431601 · Cited by 924
Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes
Ben‐Haroush, A., Yogev, Y., & Hod, M. (2004) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00985.x · Cited by 856
Gestational diabetes: The consequences of not treating
Langer, O., Yogev, Y., Most, O., & Xenakis, E. M. J. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.11.039 · Cited by 677
Silverman, B. L., Metzger, B. E., Cho, N. H., & Loeb, C. A. (1995) · Diabetes Care · doi:10.2337/diacare.18.5.611 · Cited by 643
Hoffman, L., Nolan, C., Wilson, J. D., Oats, J. J. N., & Simmons, D. (1998) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1998.tb140192.x · Cited by 570
An Increase in the Incidence of Gestational Diabetes Mellitus: Northern California, 1991–2000
Ferrara, A., Kahn, H. S., Quesenberry, C. P., Riley, C., & Hedderson, M. M. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000113623.18286.20 · Cited by 452
Glueck, C. J., Phillips, H., Cameron, D., Sieve-Smith, L., & Wang, P. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01666-6 · Cited by 430
Research works printed but not linked: 3
- Coetzee EJ, 1980, S Afr Med J, 58, 795
- Coetzee EJ, 1984, S Afr Med J, 65, 635
- Gutzin SJ, 2003, Can J Clin Pharmacol, 10, 179
Cited by
Items 801–900 of 1,001
Costa, D. N., Malek, R., & Davis, S. N. (2025) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2025.2545929 · Cited by 2
“Metformin has shown non-inferior or superior glycemic control in most clinical trials [56,57,59,62,63,65,69,73,74].”
Jiang, W., Zhang, H., Liu, X., Xie, J., & Liu, J. (2025) · Frontiers in Pediatrics · doi:10.3389/fped.2025.1604572 · Cited by 2
Wang, Z., Li, J. P., Duan, J., Shan, B., & Zhang, Y. (2025) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2025.101440 · Cited by 2
“Notably, its use has expanded to include treatment of gestational diabetes (4, 5) and polycystic ovary syndrome (6, 7).”
Intrapartum Glycemic Control and Clinical Outcomes
Bitar, G., & Bartal, M. F. (2025) · Diabetes Spectrum · doi:10.2337/dsi25-0010 · Cited by 5
Villanueva, G., Cogo, E., Buckley, B. S., Petkovic, J., Probyn, K., McIntosh, H., Bergman, H., Christou, M., Pelone, F., Kazi, F., et al. (2026) · Pregnancy · doi:10.1002/pmf2.70224 · Cited by 2
Metformin: Historical Origins, Mechanisms of Action, and Emerging Clinical Applications
Hu, Y., Zhang, X., Yang, C., Wu, X., Ye, X., Yu, J. K., & Yang, Y. (2026) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70171 · Cited by 3
“However, nearly half of women in the landmark MiG trial required supplemental insulin, complicating the interpretation of metformin‐specific effects [331].”
Ferroptosis and Its Emerging Role in Gestational Diabetes Mellitus
Xu, J., Tian, Y., Zhu, H., Peng, B., & Mo, C. (2026) · Medicine Advances · doi:10.1002/med4.70055 · Cited by 5
“Importantly, studies have suggested that metformin does not increase perinatal complications and impairment of offspring [92, 93], supporting its potential as a ferroptosis‐targeting agent.”
Cardiometabolic Health in Pregnancy
Harrington, C. M., Sarma, A., Jowell, A. R., Passarelli, J., Powe, C. E., Bello, N. A., Lewey, J., Davis, M. B., Dastmalchi, L. N., Sharma, G. V., et al. (2026) · JACC Advances · doi:10.1016/j.jacadv.2026.102804 · Cited by 3
Metformin in High Metabolic Risk Pregnancies — A Patient-Level Meta-Analysis
Mousa, A., Løvvik, T. S., Carlsen, S., Belsti, Y., Enticott, J., Tay, C. T., Nikkinen, H., Morin-Papunen, L. C., Tertti, K., Rönnemaa, T., et al. (2026) · NEJM Evidence · doi:10.1056/evidoa2500337 · Cited by 2
Self-citationMetformin in the Gestational Diabetes
Marques, P. (2014) · Journal of Diabetes Metabolic Disorders & Control · doi:10.15406/jdmdc.2014.01.00001 · Cited by 2
“However, the exposure to Metformin in the MiG trial was associated with higher frequency of prematurity, raising a concern of an unrecognized effect on the labor process [5].”
BackgroundInfluentialThe Challenge to Deliver Cost Effective Care for Patients with Gestational Diabetes Mellitus
Quinlivan, J. (2014) · Reproductive System & Sexual Disorders · doi:10.4172/2161-038x.1000144 · Cited by 2
Aziz, K. M. A. (2017) · General Medicine Open Access · doi:10.4172/2327-5146.1000e113 · Cited by 2
“Similarly, other oral medications also have not been studied well and lack long term safety data (RCT) [5-8].”
BackgroundMetformin therapy in pregnancy [Zastosowanie metforminy w ciąży]
Krupej, J., Cichocka, E., Kędzierski, L., Okopień, B., & Gumprecht, J. (2020) · Endokrynologia Polska · doi:10.5603/ep.a2020.0016 · Cited by 2
Predictive Factors of Successful Treatment of Gestational Diabetes with Metformin Monotherapy
Aboelfath, A. M. K., & el din, M. T. A. S. (2020) · Open Journal of Obstetrics and Gynecology · doi:10.4236/ojog.2020.1080097 · Cited by 2
Dunne, F., Newman, C., Alvarez‐Iglesias, A., O’Shea, P. M., Devane, D., Gillespie, P., Egan, A. M., O'Donnell, M. J., & Smyth, A. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae522 · Cited by 3
Intrapartum Care for People with Diabetes—Working towards Evidence-Based Management
Bartal, M. F. (2024) · American Journal of Perinatology · doi:10.1055/a-2405-1846 · Cited by 3
Palatnik, A., & Feghali, M. N. (2024) · American Journal of Perinatology · doi:10.1055/a-2407-0905 · Cited by 3
Biagioni, E. M., ROWE, J. C., Yendamuri, S., Wisseman, B., Zheng, D., Zhang, G., Muoio, D. M., DeVente, J., Fisher‐Wellman, K. H., Neufer, P. D., et al. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00428.2024 · Cited by 2
Farladansky‐Gershnabel, S., Sachs, D. L., Qadir, N. A. E., Ram, R. B., Biron‐Shental, T., Kovo, M., & Ravid, D. (2025) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-025-08029-z · Cited by 2
“Gestational diabetes mellitus (GDM) represents a significant health challenge, with prevalence rates ranging from 3 to 25%, depending on ethnic composition, diagnostic criteria employed, and underlying population characteristics [1, 2].”
Gestational Diabetes: Seeing Both the Forest and the Trees
Rudland, V. L., Wong, J., Yue, D. K., & Ross, G. P. (2012) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-012-0020-9 · Cited by 3
“A recent Australasian study of 751 women with GDM, randomized to receive either metformin or insulin, demonstrated less hypoglycemia but an increase in preterm birth in the group treated with metformin [25].”
MethodResultUse of metformin during pregnancy for women with polycystic ovary syndrome
Fan, H. S. (2013) · Open Journal of Obstetrics and Gynecology · doi:10.4236/ojog.2013.31021 · Cited by 2
“This is consistent with recent studies that showed metformin to be safe in pregnancy for treating GDM [35,36].”
ResultBone Disease, Gestational Diabetes Mellitus, and Health Care
Bloomgarden, Z. T. (2009) · Diabetes Care · doi:10.2337/dc09-zb07 · Cited by 2
“Janet Rowan (Auckland, New Zealand) presented rather disappointing results of a recently reported large randomized controlled trial of the use of metformin in type 2 diabetes during pregnancy (54).”
BackgroundOptimal Weighted Wilcoxon–Mann–Whitney Test for Prioritized Outcomes
Matsouaka, R., Singhal, A. B., & Betensky, R. A. (2018) · ICSA book series in statistics · doi:10.1007/978-3-319-99389-8_1 · Cited by 2
Anisya, K., Robiyanto, R., & Nurmainah, N. (2019) · Indonesian Journal of Clinical Pharmacy · doi:10.15416/ijcp.2019.8.1.72 · Cited by 3
Rol de la metformina en el tratamiento de la diabetes mellitus gestacional: situación actual
Miranda, P. J. P., Palacios, L. P. T., Cueva, J. L. C., Avilés, G. A. H., Maldonado, E. I. B., Moya, J. I. E., Moya, J. R. E., Acosta, J. M. S., & Lozada, E. M. V. (2019) · Archivos Venezolanos de Farmacología y Terapéutica · Cited by 10
Ibraheem, E. Y., & Al-Karim, I. H. A. (2023) · Al-Kitab Journal for Pure Sciences · doi:10.32441/kjps.06.01.p3 · Cited by 2
“This goes with Aboud AL Hayani, and Nasir A 2020, [9] Found that patients on metformin treatment had significantly lower glucose levels”
BackgroundInfluentialBailore, V., Basany, K., & Banda, M. (2024) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1495_23 · Cited by 2
“[51] There was no significant difference in the incidence of shoulder dystocia, respiratory distress, or early neonatal death within 1 week between the treatment groups, which was consistent with Janet A Rowan et al ., [7] Benhalima et al .”
BackgroundResultInfluentialMohammadi, M., Salehi, S., Habibzadeh, A., Mohammadi, A., & Mirzaasgari, Z. (2025) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000625 · Cited by 2
Gestational Diabetes Mellitus: a review of the diagnosis, clinical implications and management
Wong, V. (2013) · Reviews in Health Care · doi:10.7175/rhc.v4i2.481 · Cited by 2
Achieving euglycaemia in pregnancy: evidence‐based management
Fraser, R. B. (2011) · The Obstetrician & Gynaecologist · doi:10.1576/toag.13.3.149.27666 · Cited by 3
Tratamiento actual de la diabetes gestacional
Salat, D., & Aguilera, C. (2015) · Medicina Clínica · doi:10.1016/j.medcli.2015.04.014 · Cited by 6
Avaliação da frutosamina como parâmetro de controle glicêmico na gestante diabética
Feitosa, A. C. R., & Andrade, F. S. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000002990 · Cited by 3
Oral antidiabetic agents in gestational diabetes: a narrative review of current evidence
Singh, A. K., & Singh, R. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2015.982090 · Cited by 2
“(2008) Metformin versus insulin 46 [52]”
BackgroundInfluentialInsulin, other hypoglycemic drugs, and glucagon
Page, R. C. (2010) · Side effects of drugs annual · doi:10.1016/s0378-6080(10)32042-3 · Cited by 2
Milenko Pavlovic, B., & Jorge Carvajal, C. (2013) · Revista chilena de obstetricia y ginecología · doi:10.4067/s0717-75262013000300002 · Cited by 9
“Rowan et al. 2008, Australia y N. Zelandia (5) Ijäs et al. 2010, Finlandia (11) Moore et al. 2007, USA (15)”
BackgroundInfluentialGestational Diabetes: Screening, Management, Timing of Delivery
Korkmazer, E., Solak, N., & Tokgöz, V. Y. (2015) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-015-0113-3 · Cited by 2
Metformin versus Insulin for the Treatment of Gestational Diabetes
Dungan, J. S. (2009) · Yearbook of Obstetrics Gynecology and Women s Health · doi:10.1016/s1090-798x(09)79145-3 · Cited by 2
Pinkney, J. H., Tomlinson, J., & Stenhouse, E. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385083-6.00002-4 · Cited by 5
Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2014) · The Scientific Issues of Ternopil Volodymyr Hnatiuk National Pedagogical University Series pedagogy · doi:10.18370/2309-4117.2014.20.22-35 · Cited by 2
Moore, L. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-65518-5_11 · Cited by 2
Use of Antidiabetic, Antihypertensive, and Psychotropic Drugs in Pregnancy
Fasanella, D. R., Luttrell, S. E., Tejada, F. R., Ngokobi, H., & Ayuk-Tabe, M. (2018) · Side effects of drugs annual · doi:10.1016/bs.seda.2018.07.005 · Cited by 4
MATERNAL AND FETAL COMPLICATIONS OF GESTATIONAL DIABETES- REVIEW
Bernea, E. G., Mihai, A. D., Pietrosel, A., Ceauşu, I., Antohe, F., & Ionescu-Targoviste, C. (2020) · Research and Science Today Supplement · doi:10.38173/rst.2020.s1.7:55-65 · Cited by 3
Harreiter, J., & Kautzky‐Willer, A. (2011) · Wiener klinische Wochenschrift Education · doi:10.1007/s11812-011-0005-z · Cited by 2
Yanachkova, V. E., Staynova, R. A., Stoev, S., & Kamenov, Z. A. (2023) · Ginekologia Polska · doi:10.5603/gpl.91632 · Cited by 2
Hipoglicemiantes orais na gestação: metformina versus glibenclamida
Silva, J. C., Pacheco, C. P., Bizatto, J., & Bertini, A. M. (2009) · Cited by 2
Abu, H. (2012) · InTech eBooks · doi:10.5772/27856 · Cited by 6
“Recent evidence that metformin is probably safe during the first trimester of pregnancy and beyond is accumulating (82-85).”
BackgroundThompson, D. M., Berger, H. M., Feig, D. S., Gagnon, R. J., Kader, T., Keely, E., Kozak, S. E., Ryan, E. A., Sermer, M., & Vinokuroff, C. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.07.040 · Cited by 8
Contraceptive care after gestational diabetes: considerations for clinical practice
Kiley, J. W., & Griffin, L. (2015) · Diabetes Management · doi:10.2217/dmt.15.37 · Cited by 2
Recent advances in the diagnosis and management of gestational diabetes
Hasdemir, P. S., Terzi, H., & Koyuncu, F. M. (2014) · Journal of Turkish Society of Obstetric and Gynecology · doi:10.4274/tjod.71677 · Cited by 3
“3% of the women receiving metformin therapy required addition of insulin therapy, the women rather preferred metformin therapy(20).”
BackgroundGonzalez, A. G., & Adi, S. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385083-6.00001-2 · Cited by 2
Polycystic Ovary Syndrome and the Role of Metformin in Ovulation Induction
Fraga, F., Romeiro, G. A. C. S., de Sá, L. B. P. C., & Arbex, A. K. (2018) · Health · doi:10.4236/health.2018.105045 · Cited by 2
Khanna, P., Chow, L., Brydges, E., Anukam, K. C., Liu, S., Mahon, J. L., JOY, T. R., & McManus, R. M. (2019) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2019.07.005 · Cited by 3
Endocrine Diseases of Pregnancy
Edlow, A. G., & Norwitz, E. R. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2758-2.00028-7 · Cited by 2
Case report: Magnesium—A new therapeutic target in gestational diabetes mellitus?
Zhang, K. (2020) · Clinical Case Reports · doi:10.1002/ccr3.3309 · Cited by 2
Continuing Challenges in The Medical Management of Gestational Diabetes Mellitus
Jiang, S., Rajagopal, R., & Simmons, D. S. (2020) · EMJ Diabetes · doi:10.33590/emjdiabet/20-00003 · Cited by 4
Diabetes Mellitus in Pregnancy
Reyes, C. (2010) · Wiley eBooks · doi:10.1002/9781444323030.ch30 · Cited by 2
Normal Long-Term Health for Infants of Diabetic Mothers: Can We Achieve It?
Nolan, C. J. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3110 · Cited by 3
Tura, A., Göbl, C. S., & Pacini, G. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2016.1124413 · Cited by 2
“until the occurrence of a crucial study, the MiG trial.[7] In that study, metformin was proven to be equivalent to insulin in terms of the study’s primary outcome,”
BackgroundCampbell, I. W. (2021) · Current Medical Research and Opinion · doi:10.1080/03007995.2021.2003149 · Cited by 3
Baillargeon, J., & Farid, N. R. (2009) · Springer eBooks · doi:10.1007/978-0-387-09718-3_18 · Cited by 2
Diabetic Management in Labor, Delivery, and Post Delivery
McLaughlin, C., & McCance, D. R. (2010) · Wiley eBooks · doi:10.1002/9781444315196.ch21 · Cited by 2
Hypoglycaemic agents for pregnant women with polycystic ovarian syndrome
ISMAIL, K. M. K., Issa, B. G., Jones, P. W., Hanna, F., & Indusekhar, R. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009828 · Cited by 2
RetractedBoyd, A. R., & Conway, D. (2023) · Wiley eBooks · doi:10.1002/9781119636540.ch19 · Cited by 2
Developmental Programming of Nonalcoholic Fatty Liver Disease (NAFLD)
Bruce, K. D., & Cagampang, F. R. A. (2016) · Springer eBooks · doi:10.1007/978-1-4939-6386-7_12 · Cited by 1
Russkova, N. E., Shumak, A. V., & Владимировна, Т. Е. (2021) · V F Snegirev Archives of Obstetrics and Gynecology · doi:10.17816/2313-8726-2021-8-4-207-212 · Cited by 1
Fukuoka, M., Yasuhi, I., Yamashita, H., Ashimoto, K., Kurata, N., Yamaguchi, J., Koga, M., Sugimi, S., Suga, S., & Fukuda, M. (2023) · Journal of Diabetes Research · doi:10.1155/2023/9574563 · Cited by 1
“No report has yet described whether insulin therapy, especially regimens using NPH insulin alone, is associated with excessive GWG, although some investigators have reported that maternal GWG in women treated with insulin was greater than that in the metformin group [27, 28].”
BackgroundReview on pharmacological therapies for management of gestational diabetes
Shabnam, A., & Safia, B. (2023) · International Journal of Pharmaceutical Sciences and Developmental Research · doi:10.17352/ijpsdr.000047 · Cited by 2
Shestakova, M. V., Mel'nichenko, G. A., Andreeva, E. N., Sukhareva, O. Y., Vorotnikova, S. Y., Ibragimova, L. I., Фархадовна, Б. Ф., Demidova, T. Y., Геннадьевна, Д. Е., Tiselko, A. V., et al. (2024) · Diabetes Mellitus · doi:10.14341/dm13161 · Cited by 2
Shaat, N., Akel, O., Kristensen, K. H., Nilsson, A., Berntorp, K. E., & Katsarou, A. (2024) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14997 · Cited by 2
“15 Our findings are in line with those reported by Rowan et al. in the Metformin in Gestational Diabetes trial, 23 which found that capillary glucose values were strongly and independently related to predefined neonatal and maternal outcomes, including LGA frequency.”
Fetomaternal outcome in gestational diabetes mellitus: a retrospective study
Bhavana, K., Sheela, S. R., N, N. S., & Patil, D. J. (2025) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20251244 · Cited by 1
Damtie, Y., Betts, K. S., Dachew, B. A., Ayano, G., & Alati, R. (2025) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2025.112167 · Cited by 2
Beyond Glucose: The Overlooked Role of Lipids in Gestational Diabetes
Scairati, R., Laudisio, D., Imperatore, O., Masulli, M., & Colao, A. (2026) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2026.104758 · Cited by 2
Yu, H., Yu, X., Liu, Y., Alarfaj, A. A., & Hirad, A. H. (2026) · 3 Biotech · doi:10.1007/s13205-026-04785-0 · Cited by 1
Kanat, M., Abdul‐Ghani, M. A., & DeFronzo, R. A. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70987 · Cited by 1
Diabetes mellitus und Schwangerschaft
Schäfer-Graf, U. M., Kautzky‐Willer, A., & Groten, T. (2024) · Springer Reference Medizin · doi:10.1007/978-3-662-63506-3_26 · Cited by 1
DIABETES MELLITUS GESTACIONAL: UMA REVISÃO DAS OPÇÕES TERAPÊUTICAS
Costa, P. P. T., Andrade, I. R., Martins, G. C., de Oliveira, M. C., & Novaes, T. M. D. M. (2024) · Revista Ibero-Americana de Humanidades, Ciências e Educação · doi:10.51891/rease.v10i8.15188 · Cited by 1
A Metformina como opção terapêutica no diabetes mellitus gestacional: uma revisão de literatura
Klingelfus, A., Seabra, B. H. M., Techio, M. H. S., & Cruz, J. R. (2024) · Brazilian Journal of Development · doi:10.34117/bjdv10n8-029 · Cited by 1
Treatment of type 2 diabetes in pregnancy: Do we need to use metformin?
Fu, J. M., & Feig, D. S. (2025) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2025.102027 · Cited by 1
Hallack, C., Nogueira, B. V., Bomfim, M. D. L., Meireles, N. G., & Martins, W. P. (2026) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.61622/rbgo/2026rbgo18 · Cited by 1
“(11,19,20) 21-23) It is important to note that metformin crosses the placenta freely, (10) and the short-term effects on these fetuses indicate that metformin is safe while the long-term effects are still unknown.”
Shammary, N. N. A. A., & AL.Shammary, R. N. A. (2026) · Journal of Obstetrics Gynecology and Cancer Research · doi:10.24200/jogcr.11.11.1069 · Cited by 1
Metformin Trumps insulin in the treatment of gestational diabetes.
Lundberg, G. D. (2008) · PubMed Central · Cited by 1
Polycystic Ovary Syndrome in Young Women: Issues and Consequences
Norman, R. J., & Moran, L. (2014) · Nestlé Nutrition Institute Workshop series · doi:10.1159/000360259 · Cited by 1
Hypoglycaemic agents for pregnant women with polycystic ovarian syndrome
ISMAIL, K. M. K., Issa, B. G., Jones, P. W., Hanna, F., & Indusekhar, R. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009828.pub2 · Cited by 1
Schneider, A. E., Rayfield, E. J., Busta, A., & Gurevich, Y. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_15 · Cited by 2
Metformin is the lifelong partner in diabetes management: true or false?
Berne, C., & Campbell, I. W. (2011) · The British Journal of Diabetes · doi:10.1177/1474651410397255 · Cited by 2
Schwangerschaftsdiabetes in Ostafrika: eine Erkrankung, die zu wenig Beachtung findet?
Zeck, W., Lang, U. E., Panzitt, T., Oneko, O., Obure, J., & McIntyre, D. H. (2009) · Gyn�kologisch-geburtshilfliche Rundschau · doi:10.1159/000301085 · Cited by 1
Experience of Metformin Use in Gestational Diabetes: Contribution to the Debate
Swaminathan, K. (2013) · Apollo Medicine · doi:10.1016/j.apme.2013.05.005 · Cited by 1
Gestational Diabetes Mellitus: Developments in Diagnosis and Treatment
Fraser, R. B. (2009) · Women s Health · doi:10.2217/whe.09.18 · Cited by 1
A case study of systems analysis to improve service in a multidisciplinary outpatient clinic
Basu, A. (2012) · Journal of Hospital Administration · doi:10.5430/jha.v1n1p15 · Cited by 1
“A change in the service delivery process was achieved by redesigning the guidelines in light of new evidence where all women with a diagnosis of GDM were treated with oral Metformin as a first line medication on failure of nutritional modification and lifestyle changes.”
BackgroundInfluentialDiabetes mellitus und Schwangerschaft
Schaefer-Graf, U. M., & Kautzky‐Willer, A. (2011) · Springer eBooks · doi:10.1007/978-3-642-12974-2_21 · Cited by 1
Denison, F. C., & Chiswick, C. A. (2011) · Cited by 1
Considerations and Challenges for Pregnancy in Polycystic Ovary Syndrome
Han, C. S., & Werner, E. F. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8394-6_15 · Cited by 1
Barbour, L. A. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-4975-1.00014-0 · Cited by 1
Williams, D. J., & Mayahi, L. (2012) · Elsevier eBooks · doi:10.1016/b978-0-7020-3479-4.00011-8 · Cited by 1
Eficácia da metformina no tratamento do diabetes mellitus gestacional
Sales, W. B., Silva, M. R. E., do Amaral, A. R., Ferreira, B. D. S., Silva, J. C., & Bertini, A. M. (2016) · Revista Brasileira de Pesquisa em Saúde/Brazilian Journal of Health Research · doi:10.21722/rbps.v17i3.14510 · Cited by 18
Cardiovascular Disease in Pregnancy
Graves, C. R. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.037 · Cited by 1
Gastrointestinal Disorders in Pregnancy
Patrick, S. K., & Schneider, K. M. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.042 · Cited by 1
Davis, G. H. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.007 · Cited by 1
Selected Endocrine Disorders in Pregnancy
Chen, K. K. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.043 · Cited by 1
Davis, G. H. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.054 · Cited by 1
Metadata
- Authors
- Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R., & Moore, M. P.
- Affiliations
- Auckland City Hospital (NZ)
- Women's and Children's Hospital (AU)
- Auckland University of Technology (NZ)
- University of Auckland (NZ)
- Christchurch Hospital (NZ)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-05-08
- Volume
- 358
- Issue
- 19
- Pages
- 2003-2015
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2003621575
- Cited by
- 1,291
- References
- 33
- Citations by year
- 2026: 49 · 2025: 60 · 2024: 52 · 2023: 65 · 2022: 63 · 2021: 90 · 2020: 67 · 2019: 66 · 2018: 105 · 2017: 125 · 2016: 68 · 2015: 82 · 2014: 69 · 2013: 62 · 2012: 56
- FWCI
- 78.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- metformin, insulin, gestational diabetes mellitus, neonatal hypoglycemia, perinatal complications, maternal glycemic control, postpartum glucose tolerance, treatment acceptability, treatment preferences, neonatal respiratory distress, phototherapy
- MeSH terms
- Adult, Drug Therapy, Combination, Female, Gestational Age, Humans, Hypoglycemia, Hypoglycemic Agents, Infant, Newborn, Insulin, Jaundice, Neonatal, Metformin, Pregnancy, Pregnancy Complications, Cardiovascular, Pregnancy Outcome, Diabetes, Gestational, Patient Satisfaction, Premature Birth
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.